| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |